NewsHealum care plans linked to a 7.4% average HbA1c fall in an NHS RCT, Diabetes Therapy 2023Read the evidence
A man checks his blood sugar with a finger-prick test at home

For life sciences

Support more patients on therapy, for longer

Patient support programmes and market access partnerships that find the right patients and keep them on treatment, on a digital platform proven in the NHS and ready for health systems worldwide.

On treatment

Staying on treatment

A support programme delivered through Healum’s patient app and care team software helps Marcus through 12 weekly injections. Nurse Priya sees each dose, messages all who miss one, and the maker sees only totals. Fictional brand and medicine, for demo purposes.

Every MondayEach dose on his record. One not logged is flagged.

Everyone on the appDoses on time and who stays on treatment, week by week.

His plan, from his nurseTwelve weeks of support, shared from his record.

A missed doseOne message to the 41 who haven’t logged this week.

Evidence, not promises

Proven to work, built to scale

Better HbA1c control and quality of life for patients in a published NHS randomised trial.

Read the evidence

72.4%

of patients with a Healum care plan reduced their HbA1c, against 41.5% without.

NHS primary care RCT, Diabetes Therapy 2023

+8.2%

in self-rated health (EQ VAS) with Healum, against −2.8% without.

NHS primary care RCT, Diabetes Therapy 2023

Market access partnerships

Turn approval into uptake

Our platform gives you and health systems a single point of access to find eligible patients, engage them digitally, prompt clinicians to offer treatment, and track uptake and real-world outcomes.

What's included

Patient finding from GP records, using treatment criteria
Prompts for clinicians to offer treatment
Care pathways set up across primary care, hospitals and community
Direct EHR integration, built on FHIR
Digital follow-up that frees clinic capacity
Real-world uptake and outcome reports for payers
More patients treatedPatient finding and clinician prompts close the gap from eligible to treated.
Proven in NHS pathwaysLive in NHS care, including an Eli Lilly-funded obesity pathway at UHB, and ready to launch in as little as 13 weeks.
Talk to us
A nurse checks a woman’s blood pressure at home

Patient support programmes

A platform that keeps patients on therapy

A patient app and web portal in your brand, software for each patient’s clinical team, and real-world insights for you, all connected for the whole programme.

What's included

Reminders and plans in the patient app and portal
Side effects logged in the app and seen in the clinician workspace
One message to all who miss a dose, from their clinic
Education on the therapy, side effects and lifestyle, all in the app
A real-world insights dashboard, anonymised for you
Better outcomes, proven72% of patients cut their HbA1c with a Healum care plan in an NHS trial, vs 42% without.
Actionable real-world insightAnonymised insight on where patients drop off, so you can act sooner.
Book a demo
A smiling woman checks her blood sugar at home

Hybrid and real-world trials

Run trials in routine care

Recruit eligible participants through their care teams and records, then support them at home with digital engagement, ePROs and remote data collection.

What's included

Feasibility and recruitment from GP records, by trial criteria
Remote and in-clinic visits, booked in the app
ePROs, questionnaires and digital endpoints from our tracker library
Reminders and messaging for retention
Side effects logged and seen by site teams
Pragmatic, post-approval and real-world studies
Proven in an NHS RCTOur platform ran a published randomised trial across 15 NHS GP practices.
Participants who stayLess travel and digital support ease the burden of taking part, with patient-reported outcomes and experience built in.
Book a demo
A clinician smiles as she talks on the phone at her laptop

Why Healum

Proven, connected and quick to launch

Healum already runs in live NHS and private settings, and connects to the clinical systems patients’ care teams use.

EMIS WebSystmOne

Evidence and assurance

Published RCT evidence in type 2 diabetes (Diabetes Therapy, 2023)

Eli Lilly-funded obesity pathway at University Hospitals Birmingham

Clinical safety: DCB0129 compliant

Live in as little as 13 weeks

Talk to us about your therapy or launch

We’ll show you the patient app and portal, the clinicians’ software and the real-world insights.